VAERS reports by lot

Merck HPV lot M036059: VAERS reports

91 VAERS reports list lot M036059 as a Merck HPV vaccine, received between 2016-12-21 and 2020-06-29. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
91
Reports
11%
Marked serious
0
With a death outcome
17
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological1722%
General / Systemic (non-local)1620%
Allergic / Anaphylactic1013%
Injection-site / Local reaction79%
Musculoskeletal68%
Gastrointestinal56%
Dermatological (non-injection-site)56%
Cardiac / Cardiovascular45%
Respiratory45%
Thrombotic / Hematological34%
Autoimmune / Immune-mediated11%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

California63
Oregon5
North Dakota3
Nevada2
Utah2
Washington2
Colorado2
Arizona1
Kansas1
New Mexico1
Montana1
Texas1

Reports by month received

2016-121
2017-012
2017-024
2017-036
2017-045
2017-059
2017-062
2017-0744
2017-085
2017-094
2017-101
2017-113
2018-041
2019-021
2019-071
2020-051
2020-061

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.